Ido Laskov

Tel Aviv University

Papers

1

Total Citations

24

H-Index

1

About

Ido Laskov is a clinician-researcher whose work centers on the intersection of gynecologic oncology, surgical innovation, and patient safety. His primary research areas include the perioperative management of endometrial cancer, with a particular focus on thromboembolic risk in robotic-assisted surgery. In his most-cited paper, "Risk of Thromboembolic Disease With Cost Estimates in Patients Undergoing Robotic Assisted Surgery for Endometrial Cancer and Review of the Literature" (2018, 24 citations), Laskov provides critical insights into the incidence and economic burden of venous thromboembolism (VTE) following minimally invasive procedures. This work not only quantifies the clinical risk but also offers a cost-analysis framework, helping to guide prophylactic strategies and resource allocation in surgical oncology. By bridging surgical outcomes with health economics, Laskov’s contributions support evidence-based decision-making for high-risk patient populations. His research is particularly valuable for surgeons and oncologists seeking to optimize both safety and cost-effectiveness in robotic surgery. Through this focused investigation, Laskov has established himself as a thoughtful voice in the evolving landscape of gynecologic cancer care.

Research Focus

Key Achievements

1
H-Index
1
Papers
24
Total Citations
24
Avg Citations/Paper
🏆 Most Cited Paper
Risk of Thromboembolic Disease With Cost Estimates in Patients Undergoing Robotic Assisted Surgery for Endometrial Cancer and Review of the Literature
24 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Tel Aviv University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago